Robert Burns
Stock Analyst at H.C. Wainwright
(4.90)
# 271
Out of 4,703 analysts
1063
Total ratings
51.5%
Success rate
26.3%
Average return
Main Sectors:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PMVP PMV Pharmaceuticals | Reiterated: Buy | $5 | $1.29 | +287.60% | 22 | Sep 4, 2026 | |
| BLSM BlossomHill Therapeutics | Initiated Coverage: Buy | $35 | $22.01 | +59.02% | 1 | Sep 1, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $195 → $280 | $210.02 | +33.32% | 47 | Aug 27, 2026 | |
| ZYME Zymeworks | Reiterated: Buy | $51 → $55 | $29.19 | +88.42% | 46 | Aug 26, 2026 | |
| INBX Inhibrx Biosciences | Initiated Coverage: Buy | $245 | $121.17 | +102.20% | 1 | Aug 24, 2026 | |
| COGT Cogent Biosciences | Reiterated: Buy | $55 | $34.76 | +58.23% | 28 | Aug 21, 2026 | |
| RLAY Relay Therapeutics | Reiterated: Buy | $28 → $29 | $19.04 | +52.31% | 36 | Aug 21, 2026 | |
| ELTX Elicio Therapeutics | Reiterated: Buy | $23 | $2.41 | +854.36% | 16 | Aug 21, 2026 | |
| HURA TuHURA Biosciences | Reiterated: Buy | $10 | $2.14 | +367.29% | 8 | Aug 20, 2026 | |
| TNGX Tango Therapeutics | Reiterated: Buy | $66 → $68 | $22.52 | +201.95% | 23 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $22.09 | +35.81% | 12 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 → $47 | $30.95 | +51.86% | 18 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $9.59 | +181.54% | 5 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $27 | $12.86 | +109.95% | 49 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $25 | $13.91 | +79.73% | 16 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $6.81 | +208.37% | 34 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $2.12 | +418.87% | 42 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $13 → $3 | $1.79 | +67.60% | 11 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $5.46 | +46.52% | 25 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $21 | $3.58 | +486.59% | 8 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $34 | $26.14 | +30.07% | 31 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $2.48 | +182.26% | 23 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 → $65 | $59.32 | +9.58% | 12 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $4.35 | +198.85% | 7 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 | $59.01 | -5.10% | 25 | Jul 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $1.57 | +600.64% | 30 | Jun 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.36 | - | 45 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $2.08 | +669.23% | 1 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $33 → $35 | $27.05 | +29.39% | 3 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $3.13 | +315.34% | 10 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.09 | - | 13 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $23.17 | +81.27% | 14 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $3.90 | +79.49% | 4 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.40 | - | 34 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $8.98 | +222.94% | 7 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $130 | $103.76 | +25.29% | 104 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.60 | - | 23 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $11 | $1.97 | +458.38% | 32 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $15.04 | - | 44 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $2.24 | +257.14% | 12 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $9.76 | n/a | 29 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $27.50 | n/a | 8 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0008 | n/a | 6 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.241 | n/a | 19 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 → $20 | $1.39 | n/a | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0992 | n/a | 13 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $38.60 | n/a | 18 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $4.85 | n/a | 7 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $3.71 | n/a | 15 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $1.78 | n/a | 16 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.40 | n/a | 8 | Mar 5, 2021 |
PMV Pharmaceuticals
Sep 4, 2026
Reiterated: Buy
Price Target: $5
Current: $1.29
Upside: +287.60%
BlossomHill Therapeutics
Sep 1, 2026
Initiated Coverage: Buy
Price Target: $35
Current: $22.01
Upside: +59.02%
Revolution Medicines
Aug 27, 2026
Reiterated: Buy
Price Target: $195 → $280
Current: $210.02
Upside: +33.32%
Zymeworks
Aug 26, 2026
Reiterated: Buy
Price Target: $51 → $55
Current: $29.19
Upside: +88.42%
Inhibrx Biosciences
Aug 24, 2026
Initiated Coverage: Buy
Price Target: $245
Current: $121.17
Upside: +102.20%
Cogent Biosciences
Aug 21, 2026
Reiterated: Buy
Price Target: $55
Current: $34.76
Upside: +58.23%
Relay Therapeutics
Aug 21, 2026
Reiterated: Buy
Price Target: $28 → $29
Current: $19.04
Upside: +52.31%
Elicio Therapeutics
Aug 21, 2026
Reiterated: Buy
Price Target: $23
Current: $2.41
Upside: +854.36%
TuHURA Biosciences
Aug 20, 2026
Reiterated: Buy
Price Target: $10
Current: $2.14
Upside: +367.29%
Tango Therapeutics
Aug 18, 2026
Reiterated: Buy
Price Target: $66 → $68
Current: $22.52
Upside: +201.95%
Aug 17, 2026
Reiterated: Buy
Price Target: $30
Current: $22.09
Upside: +35.81%
Aug 17, 2026
Reiterated: Buy
Price Target: $44 → $47
Current: $30.95
Upside: +51.86%
Aug 10, 2026
Reiterated: Buy
Price Target: $27
Current: $9.59
Upside: +181.54%
Aug 10, 2026
Reiterated: Buy
Price Target: $25 → $27
Current: $12.86
Upside: +109.95%
Aug 10, 2026
Reiterated: Buy
Price Target: $20 → $25
Current: $13.91
Upside: +79.73%
Aug 7, 2026
Reiterated: Buy
Price Target: $21
Current: $6.81
Upside: +208.37%
Aug 6, 2026
Reiterated: Buy
Price Target: $11
Current: $2.12
Upside: +418.87%
Jul 31, 2026
Downgraded: Hold
Price Target: $13 → $3
Current: $1.79
Upside: +67.60%
Jul 29, 2026
Reiterated: Buy
Price Target: $8
Current: $5.46
Upside: +46.52%
Jul 20, 2026
Reiterated: Buy
Price Target: $27 → $21
Current: $3.58
Upside: +486.59%
Jul 10, 2026
Reiterated: Buy
Price Target: $32 → $34
Current: $26.14
Upside: +30.07%
Jul 9, 2026
Reiterated: Buy
Price Target: $7
Current: $2.48
Upside: +182.26%
Jul 9, 2026
Reiterated: Buy
Price Target: $56 → $65
Current: $59.32
Upside: +9.58%
Jul 6, 2026
Reiterated: Buy
Price Target: $13
Current: $4.35
Upside: +198.85%
Jul 2, 2026
Reiterated: Buy
Price Target: $56
Current: $59.01
Upside: -5.10%
Jun 16, 2026
Reiterated: Buy
Price Target: $11
Current: $1.57
Upside: +600.64%
Jun 8, 2026
Downgraded: Hold
Price Target: n/a
Current: $1.36
Upside: -
Jun 4, 2026
Initiated Coverage: Buy
Price Target: $16
Current: $2.08
Upside: +669.23%
Jun 3, 2026
Rated: Buy
Price Target: $33 → $35
Current: $27.05
Upside: +29.39%
Jun 1, 2026
Reiterated: Buy
Price Target: $13
Current: $3.13
Upside: +315.34%
Jun 1, 2026
Downgraded: Hold
Price Target: n/a
Current: $1.09
Upside: -
Jun 1, 2026
Reiterated: Buy
Price Target: $42
Current: $23.17
Upside: +81.27%
May 28, 2026
Reiterated: Buy
Price Target: $7
Current: $3.90
Upside: +79.49%
May 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $4.40
Upside: -
May 1, 2026
Reiterated: Buy
Price Target: $29
Current: $8.98
Upside: +222.94%
Apr 27, 2026
Reiterated: Buy
Price Target: $130
Current: $103.76
Upside: +25.29%
Apr 21, 2026
Reiterated: Hold
Price Target: n/a
Current: $4.60
Upside: -
Apr 16, 2026
Reiterated: Buy
Price Target: $8 → $11
Current: $1.97
Upside: +458.38%
Apr 13, 2026
Downgraded: Sell
Price Target: n/a
Current: $15.04
Upside: -
Feb 13, 2026
Maintained: Buy
Price Target: $8
Current: $2.24
Upside: +257.14%
Aug 19, 2025
Reiterated: Hold
Price Target: n/a
Current: $9.76
Upside: n/a
Sep 3, 2024
Rated: Hold
Price Target: n/a
Current: $27.50
Upside: n/a
Jul 16, 2024
Rated: Hold
Price Target: n/a
Current: $0.0008
Upside: n/a
May 24, 2024
Rated: Hold
Price Target: n/a
Current: $0.241
Upside: n/a
Mar 21, 2024
Reiterated: Buy
Price Target: $110 → $20
Current: $1.39
Upside: n/a
Jan 8, 2024
Downgraded: Hold
Price Target: n/a
Current: $0.0992
Upside: n/a
Mar 21, 2023
Reiterated: Hold
Price Target: n/a
Current: $38.60
Upside: n/a
Mar 17, 2023
Reiterated: Buy
Price Target: $22
Current: $4.85
Upside: n/a
May 10, 2022
Reiterated: Buy
Price Target: $11
Current: $3.71
Upside: n/a
Oct 22, 2021
Maintained: Sell
Price Target: n/a
Current: $1.78
Upside: n/a
Mar 5, 2021
Reiterated: Buy
Price Target: $10
Current: $1.40
Upside: n/a